EAM
CVS icon

Empirical Asset Management’s CVS Health CVS Stock Holding History

Empirical Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566K Buy
+5,473
New +$489K 0.13% 216
2025
Q2 		– Sell
-3,752
Closed -$254K – 323
2025
Q1 		$254K Sell
3,752
-33,133
-90% -$1.98M 0.09% 270
2024
Q4 		$194K Buy
36,885
+32,860
+816% +$1.84M 0.06% 309
2024
Q3 		$253K Sell
4,025
-3,637
-47% -$212K 0.09% 255
2024
Q2 		$453K Sell
7,662
-3,720
-33% -$233K 0.17% 178
2024
Q1 		$726K Buy
11,382
+7,285
+178% +$556K 0.35% 77
2023
Q4 		$323K Buy
4,097
+6
+0.1% +$427 0.26% 127
2023
Q3 		$286K Sell
4,091
-61
-1% -$4.32K 0.25% 125
2023
Q2 		$287K Sell
4,152
-98
-2% -$6.97K 0.25% 119
2023
Q1 		$316K Sell
4,250
-6,793
-62% -$570K 0.3% 105
2022
Q4 		$387K Buy
11,043
+6,336
+135% +$611K 0.41% 97
2022
Q3 		$449K Sell
4,707
-362
-7% -$35.8K 0.49% 84
2022
Q2 		$470K Buy
5,069
+920
+22% +$89.8K 0.5% 63
2022
Q1 		$420K Sell
4,149
-5,240
-56% -$550K 0.4% 89
2021
Q4 		$969K Buy
+9,389
New +$868K 0.94% 31

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Empirical Asset Management's CVS Position: Q2 2026 in Review

Empirical Asset Management opened a new position in CVS Health (CVS) in Q2 2026: 5,473 shares worth $566K. The stake represents 0.13% of the portfolio and ranks #216 among its holdings. This is a return to the name: Empirical Asset Management previously reported a position in CVS as recently as Q1 2025.

Empirical Asset Management first reported a position in CVS in Q4 2021 and has held it in 15 quarters since. The position peaked at $969K in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Empirical Asset Management held 5,473 shares of CVS Health worth $566K as of Q2 2026.
  • CVS Health was a new Empirical Asset Management position in Q2 2026.
  • CVS Health made up 0.13% of Empirical Asset Management's portfolio in Q2 2026, its #216 holding.
  • Empirical Asset Management first reported a position in CVS Health in Q4 2021 and has held it in 15 quarters since.
  • Empirical Asset Management's CVS Health position peaked at $969K in Q4 2021.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.